Skip to content
PeptideAgent

Compounding pharmacies in New York

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The New York State Board of Pharmacy (State Education Department, Office of the Professions) regulates compounding pharmacies in New York. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

New York at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving New York

No verified compounding pharmacies serving New York are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in New York

In New York, the State Education Department registers pharmacies and licenses pharmacists under Education Law Article 137 (sections 6800 and following), with the State Board of Pharmacy advising on standards and discipline, and Commissioner's regulations in 8 NYCRR Part 63 set practice rules. Education Law section 6808-b requires every nonresident establishment (a pharmacy, manufacturer, wholesaler, or outsourcing facility outside New York, including internet pharmacies) that ships, mails, or delivers prescription drugs to New York patients to register with the Department, be licensed and in good standing in its home state, and keep retrievable records of drugs shipped into New York; 8 NYCRR 63.8 implements that requirement. On sterile compounding standards, 8 NYCRR Part 63 does not adopt USP chapters 795 or 797 by number. Instead, the Regents rule 8 NYCRR 29.2 makes it unprofessional conduct for a health professional to fail to adhere to applicable practice guidelines, as determined by the Commissioner, for compounding sterile drugs and products, and 8 NYCRR 63.7 requires pharmacists to complete at least three hours of compounding continuing education, consistent with current compounding standards, in each registration period beginning on or after January 1, 2023. New York has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [3] [4] [5] [6] [7]

Compounded GLP-1 access in New York

A telehealth GLP-1 program shipping into New York must use a pharmacy registered as a nonresident establishment under Education Law section 6808-b, which patients can verify on the Office of the Professions license lookup. [3] [10]

Research use only sellers in New York

Education Law Article 137 limits dispensing of prescription drugs to registered pharmacies and licensed practitioners, and section 6808-b requires registration of any out-of-state establishment shipping prescription drugs into New York, including internet sellers. [3] [11]

New York notes on specific peptides

  • Semaglutide: Available branded by prescription, including from a New York-licensed telehealth provider under Public Health Law Article 29-G. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [10]
  • Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and an out-of-state pharmacy must be registered under Education Law section 6808-b to ship it into New York. [3] [10]

How to check a compounding pharmacy in New York

  1. Search the New York State Board of Pharmacy (State Education Department, Office of the Professions) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration New York requires before it ships to you. [1] [3] [4] [5] [6] [7]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New York. [3] [11]

Common questions in New York

Can an out-of-state pharmacy ship compounded peptides to me in New York?

Only if it is registered with the State Education Department as a nonresident establishment under Education Law section 6808-b. Check the Office of the Professions registration lookup before ordering. [3] [4]

Can a New York pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8] [9]

All peptide legal questions for New York

Sources

  1. [1]New York State Education Department, Office of the Professions: Pharmacy
  2. [2]New York Public Health Law Article 29-G, Telehealth delivery of services
  3. [3]New York Education Law section 6808-b, Registration of nonresident establishments
  4. [4]8 NYCRR 63.8, Registration of nonresident establishments
  5. [5]8 NYCRR Part 63, Pharmacy (Regulations of the Commissioner of Education, including 63.7 continuing education)
  6. [6]8 NYCRR Part 29, Unprofessional conduct (section 29.2, general provisions for health professions)
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts